| Financial Year |
March 31 2023 |
| Monetary Funds |
377,805,491.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,162,116.82 |
| Advances to Suppliers |
4,716,606.21 |
| Other Receivables |
2,784,486.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
180,683.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
150,063,695.25 |
| Total Current Assets |
537,713,079.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,787,818,925.25 |
| Fixed Assetes |
144,626,292.66 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,229,170.86 |
| R&D expenses |
-- |
| Goodwill |
196,702,272.87 |
| Long-Term Deferred and Prepaid Expenses |
253,671,696.40 |
| Deferred Income Tax Assets |
121,047,584.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,630,402,892.56 |
| Total Assets |
3,168,115,972.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
35,917,883.67 |
| Accounts Received In Advance |
337,206.39 |
| Employee Compensation Payable |
12,090,221.91 |
| Taxes Payable |
5,546,025.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
971,040.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,761,989.73 |
| Other Current Liabilities |
6,058,040.98 |
| Sub-Total of Current Liabilities |
202,951,593.65 |
| Long-term Loans |
715,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,576,737.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
727,034,090.23 |
| Total Liabilities |
929,985,683.88 |
| Paid-In Capital(Or Share Stock) |
598,280,384.00 |
| Capital Surplus |
2,022,024,146.50 |
| Surplus Reserve |
28,346,059.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-408,813,497.16 |
| Minority Stockholder's Interest |
-1,696,006.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,239,826,295.07 |
| Owner's Equity（Stockholder's Equity） |
2,238,130,288.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,168,115,972.00 |
